Treatment of dwarfism with recombinant human insulin-like growth factor-1.
about
Meta-Analysis of Serum Insulin-Like Growth Factor 1 in Alzheimer's Disease.Too short and too poor: A tale of two siblingsPropionic acidemia: clinical course and outcome in 55 pediatric and adolescent patients.Mecasermin in Insulin Receptor-Related Severe Insulin Resistance Syndromes: Case Report and Review of the Literature.
P2860
Treatment of dwarfism with recombinant human insulin-like growth factor-1.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Treatment of dwarfism with recombinant human insulin-like growth factor-1.
@en
Treatment of dwarfism with recombinant human insulin-like growth factor-1.
@nl
type
label
Treatment of dwarfism with recombinant human insulin-like growth factor-1.
@en
Treatment of dwarfism with recombinant human insulin-like growth factor-1.
@nl
prefLabel
Treatment of dwarfism with recombinant human insulin-like growth factor-1.
@en
Treatment of dwarfism with recombinant human insulin-like growth factor-1.
@nl
P2093
P2860
P1476
Treatment of dwarfism with recombinant human insulin-like growth factor-1.
@en
P2093
Dirk Schnabel
Joachim Wölfle
Markus Bettendorf
Michael B Ranke
P2860
P304
P356
10.3238/ARZTEBL.2009.0703
P577
2009-10-23T00:00:00Z